Fundraising Fox

Kaiser Permanente Ventures2015 Investments

4 investments dated 2015 · listed companies and verified rows first · show all

Freenomefreenome.cominNASDAQ: FRNMOct 2015

Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon

Riley Ennis(Co-Founder and Chief Product Officer)Charles Roberts(Director)Gabriel Otte(Director)

BoardStuart Lawson(Director)

Omada Healthomadahealth.comin𝕏NASDAQ: OMDAJul 2015

Omada Health provides virtual-first, integrated care programs for chronic disease management, delivered as data-driven solutions for employers, health plans, and healthcare organizations.

Digital HealthHealthtechWellness & FitnessSan Francisco, US

Andrew DiMichelle(Executive Officer, Director)Adrian James(Executive Officer, Director)Sean Duffy(Executive Officer, Director)

BoardJonathan Root(Director)Casper De Clercq(Director)Balaji Srinivasan(Director)

Startup Healthstartuphealth.comin𝕏Jun 2015

StartUp Health is a membership-based private community platform that connects health innovators, founders, investors, and healthcare executives for networking, collaboration, and knowledge exchange.

Digital HealthEnterprise SoftwareSaaSNew York, US

Steven Krein(Executive Officer, Director)Unity Stoakes(Executive Officer, Director)Bari Krein(Executive Officer)

BoardWayne Kimmel(Director)Jerry Levin(Director)

Trivasculartrivascular.comin𝕏Aug 2015

Endologix develops medical devices for treating vascular disease, including the DETOUR™ System for endovascular aortic repair (EVAR) procedures.

HealthtechMedical DevicesSanta Rosa, US

MICHAEL V. CHOBOTOV(Executive Officer)SHARI L. O'QUINN(Executive Officer)MICHAEL R. KRAMER(Executive Officer)KIMBERLEY ELTING(Executive Officer)CHRISTOPHER CHAVEZ(Executive Officer, Director)VIVEK K. JAYARAMAN(Executive Officer)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.